Home > Library
Search results : renminbi
2023-02-01Our fintech finbuzz analytic report shines fresh light on the current global macro economic outlook.
2022-10-22This ebook delves into the modern collection of prescient economic insights with executive annotations and personal reflections.
2022-08-01Our fintech finbuzz analytic report shines fresh light on the current global macro economic outlook.
2022-02-01Our fintech finbuzz analytic report shines fresh light on the current global macro economic outlook.
2021-12-05This ebook delves into the modern collection of prescient economic insights with executive annotations and personal reflections.
2021-08-19Our fintech finbuzz analytic report shines fresh light on the current global macro economic outlook.
2021-01-23Our fintech finbuzz analytic report shines fresh light on the current global macro economic outlook.
2020-08-07Our fintech finbuzz analytic report shines fresh light on the current global macro financial outlook.
2020-03-12 09:32:00 Thursday ET
Google CEO Eric Schmidt and his co-authors show the innovative corporate culture and mission of the Internet search tech titan. Eric Schmidt, Jonathan Ro
2024-02-04 08:28:00 Sunday ET
Our proprietary alpha investment model outperforms most stock market indexes from 2017 to 2024. Our proprietary alpha investment model outperforms the ma
2019-03-13 12:35:00 Wednesday ET
Uber seeks an IPO in close competition with its rideshare rival Lyft and other tech firms such as Slack, Pinterest, and Palantir. Uber expects to complete o
2019-11-11 09:36:00 Monday ET
Apple upstream semiconductor chipmaker TSMC boosts capital expenditures to $15 billion with almost 10% revenue growth by December 2019. Due to high global d
2017-07-01 08:40:00 Saturday ET
The Economist interviews President Donald Trump and spots the keyword *reciprocity* in many aspects of Trumponomics from trade and taxation to infrastructur
2019-01-10 17:31:00 Thursday ET
The recent Bristol-Myers Squibb acquisition of American Celgene is the $90 billion biggest biotech deal in history. The resultant biopharma goliath would be